Cat.#: ACPP-1547
| Despition | CA14 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1652 | Human WWC1 Protein (AC1652) | 5 µg | inquiry |
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
| ACPP-1630 | Human ENO2 Protein, His (AC1630) | 2 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1052 | Recombinant Human PGRPS Protein (Fc Tag) (AC1052) | 50 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1517 | Human PGRN Protein (AC1517) | 2 µg | inquiry |
| ACPP-1772 | Human CALB2 Protein (AC1772) | 5 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.